Health
1 read
New Experimental Pill Offers Promise in Treating Pancreatic Cancer

Want the full story?
Read the complete article at KTSM
AI Summary
A groundbreaking experimental pill is being developed to combat pancreatic cancer, a disease that is projected to affect approximately 67,000 individuals in the U.S. this year alone. The American Cancer Society highlights the urgency of this development, as more than 52,000 people are expected to succumb to the illness in 2023. This new treatment could potentially change the prognosis for patients facing this aggressive cancer, which has historically had limited treatment options. The ongoing research aims to provide hope for those diagnosed and their families.
cancer health treatment research pancreatic-cancer
People & Organizations
American Cancer Society